During the past decade, Lehigh Valley Hospital - Muhlenberg conducted 141 clinical trials. In the 10-year time frame, 141 clinical trials started and 103 clinical trials were completed, i.e. on average, 73% percent of trials that started reached the finish line to date. In the past 5 years, 57 clinical trials started and 64 clinical trials were completed. i.e. 112.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lehigh Valley Hospital - Muhlenberg" #1 sponsor was "National Cancer Institute (NCI)" with 98 trials, followed by "Children's Oncology Group" with 56 trials sponsored, "Alliance for Clinical Trials in Oncology" with 35 trials sponsored, "SWOG Cancer Research Network" with 26 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 26 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lehigh Valley Hospital - Muhlenberg" #1 collaborator was "National Cancer Institute (NCI)" with 145 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 3 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Lehigh Valley Hospital - Muhlenberg" are "Stage IV Lung Cancer AJCC v8" (8 trials), "Acute Lymphoblastic Leukemia" (7 trials), "Invasive Breast Carcinoma" (6 trials), "Recurrent Breast Carcinoma" (6 trials) and "Adult Rhabdomyosarcoma" (5 trials). Many other conditions were trialed in "Lehigh Valley Hospital - Muhlenberg" in a lesser frequency.

Most popular intervention types in "Lehigh Valley Hospital - Muhlenberg" are "Drug" (190 trials), "Other" (153 trials), "Biological" (98 trials), "Procedure" (67 trials) and "Radiation" (47 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (71 trials), "Quality-of-Life Assessment" (59 trials), "Questionnaire Administration" (42 trials), "Cisplatin" (31 trials) and "Cyclophosphamide" (30 trials). Other intervention names were less common.

The vast majority of trials in "Lehigh Valley Hospital - Muhlenberg" are 219 trials for "All" genders, 23 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Lehigh Valley Hospital - Muhlenberg". undefined are not yet recruiting, 64 are recruiting, 110 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 56 completed trials in Lehigh Valley Hospital - Muhlenberg, 5 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Lehigh Valley Hospital - Muhlenberg, 7 "Phase 1" clinical trials were conducted, 93 "Phase 2" clinical trials and 135 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".